ALDH1A1 and prostate carcinoma: The Wnt pathway was reported to directly regulate ALDH1A1 expression through β-catenin/TCF-dependent transcription, and inhibition of the Wnt/β-catenin signalling pathway was demonstrated to suppress the viability of prostate cancer cells with relatively high ALDH1A1 expression.16